Citation: Dt. Baird, Is there a place for different isoforms of FSH in clinical medicine? IV. The clinician's point of view, HUM REPR, 16(7), 2001, pp. 1316-1318
Authors:
Baird, DT
Collins, J
Cooke, I
Glasier, A
Jacobs, HS
La Vecchia, C
Stock, G
Vercellini, P
Cohen, J
Crosignani, PG
Diczfalusy, E
Evers, JLH
Skouby, S
Tarlatzis, B
Citation: Dt. Baird et al., Ovarian and endometrial function during hormonal contraception, HUM REPR, 16(7), 2001, pp. 1527-1535
Citation: J. Bartley et al., Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation, HUM REPR, 16(10), 2001, pp. 2098-2102
Citation: D. Kinniburgh et al., Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride, J ANDROLOGY, 22(1), 2001, pp. 88-95
Authors:
Souza, CJH
MacDougall, C
Campbell, BK
McNeilly, AS
Baird, DT
Citation: Cjh. Souza et al., The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene, J ENDOCR, 169(2), 2001, pp. R1-R6
Citation: Bk. Campbell et Dt. Baird, Inhibin A is a follicle stimulating hormone-responsive marker of granulosacell differentiation, which has both autocrine and paracrine actions in sheep, J ENDOCR, 169(2), 2001, pp. 333-345
Authors:
Slayden, OD
Nayak, NR
Burton, KA
Chwalisz, K
Cameron, ST
Critchley, HOD
Baird, DT
Brenner, RM
Citation: Od. Slayden et al., Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium, J CLIN END, 86(6), 2001, pp. 2668-2679
Citation: Os. Tang et al., Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases, CONTRACEPT, 64(1), 2001, pp. 29-32
Citation: D. Hapangama et al., The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle, CONTRACEPT, 63(3), 2001, pp. 123-129
Authors:
Martin, CW
Riley, SC
Everington, D
Groome, NP
Riemersma, RA
Baird, DT
Anderson, RA
Citation: Cw. Martin et al., Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men, HUM REPR, 15(7), 2000, pp. 1515-1524
Authors:
Martin, CW
Anderson, RA
Cheng, L
Ho, PC
van der Spuy, Z
Smith, KB
Glasier, AF
Everington, D
Baird, DT
Citation: Cw. Martin et al., Potential impact of hormonal male contraception: crosscultural implications for development of novel preparations, HUM REPR, 15(3), 2000, pp. 637-645
Authors:
Baird, DT
Collins, J
Cooke, I
Cohen, J
Evers, JLH
Glasier, A
Nieschlag, E
Van Steirteghem, A
Vercellini, P
Mishell, DR
Devroey, P
Diczfalusy, E
Diedrich, K
Edwards, RG
Engels, S
Liebaers, I
Lindner, A
Ragni, G
Tarlatzis, BC
Crosignani, PG
Rubin, BL
Citation: Dt. Baird et al., Optimal use of infertility diagnostic tests and treatments, HUM REPR, 15(3), 2000, pp. 723-732
Citation: Dt. Baird et Af. Glasier, The science, medicine, and future of contraception (Reprinted from BMJ, vol 319, pg 969-972, 1999), WEST J MED, 172(5), 2000, pp. 321-324
Authors:
Nayak, NR
Critchley, HOD
Slayden, OD
Menrad, A
Chwalisz, K
Baird, DT
Brenner, RM
Citation: Nr. Nayak et al., Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: Potential relevance to menstruation, J CLIN END, 85(9), 2000, pp. 3442-3452
Authors:
Bartley, J
Tong, S
Everington, D
Baird, DT
Citation: J. Bartley et al., Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost, CONTRACEPT, 62(6), 2000, pp. 297-303
Authors:
Arulkumaran, S
Baird, DT
Barlow, DH
Baskett, T
Benedet, JL
Brennicke, S
Brosens, I
Cain, J
Fisk, NM
Fraser, I
Hale, R
Chung, HP
Ingemarsson, I
Johnson, TRB
Kitchener, HC
Lalonde, A
Moodley, J
Neilson, JP
Chye, NS
Smith, SK
Symonds, EM
Citation: S. Arulkumaran et al., Novartis Foundation/RCOG International Conference: Recruitment and Training of Academic Staff in Obstetrics and Gynaecology - 9 & 10 July 1998 - 41 Portland Place, London WI, UK, BEST P R CL, 13(3), 1999, pp. IX-XIII
Authors:
Fauser, BCJM
Devroey, P
Yen, SSC
Gosden, R
Crowley, WF
Baird, DT
Bouchard, P
Citation: Bcjm. Fauser et al., Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks, HUM REPR, 14(11), 1999, pp. 2681-2686
Citation: Ra. Anderson et al., Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment, HUM REPR, 14(10), 1999, pp. 2665-2668